IFP Advisors, Inc - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 1 filers reported holding ARRAY BIOPHARMA INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q2 2021$000.00%
Q1 2021$000.00%
Q4 2020$000.00%
Q3 2020$000.00%
Q2 2020$000.00%
Q1 2020$0
-100.0%
0
-100.0%
0.00%
-100.0%
Q4 2018$40,0002,8310.00%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q2 2021
NameSharesValueWeighting ↓
Redmile Group, LLC 17,224,428$281,103,00010.86%
BVF INC/IL 5,062,768$82,624,0008.38%
First Light Asset Management, LLC 1,675,148$27,338,0006.00%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 851,500$13,888,0005.42%
EcoR1 Capital, LLC 3,049,312$49,765,0004.99%
X-Square Capital, LLC 167,338$2,731,0002.88%
Eversept Partners, LP 357,727$5,838,1052.71%
SECTORAL ASSET MANAGEMENT INC 1,031,650$16,837,0001.85%
Copernicus Capital Management, LLC 131,418$2,145,0001.71%
Asymmetry Capital Management, L.P. 81,649$1,333,0001.67%
View complete list of ARRAY BIOPHARMA INC shareholders